Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-03-26 Pecora Andrew L Director Grant or award +848 $3.08 $3K 343,379
2015-03-18 Wei Eric Director Sale −100,000 $3.20 $320K 2,122,988
2015-03-12 Pecora Andrew L Director Grant or award +688 $3.80 $3K 342,531
2015-02-26 Pecora Andrew L Director Grant or award +6.72 $3.89 $26 341,843
2015-02-12 Pecora Andrew L Director Grant or award +753 $3.47 $3K 339,456
2015-02-12 Pecora Andrew L Director Grant or award +1,715 $3.77 $6K 341,171
2015-02-05 VACZY CATHERINE M General Counsel Grant or award +30,000 79,359
2015-02-05 VACZY CATHERINE M General Counsel Shares withheld for taxes −12,096 $3.54 $43K 67,263
2015-01-29 Pecora Andrew L Director Grant or award +746 $3.50 $3K 347,508
2015-01-22 TRABER PETER G Director Grant or award · Stock Option (right to purchase) +26,500 26,500
2015-01-16 BERMAN RICHARD J Director Grant or award +10,766 28,766
2015-01-16 Mazzo David J Chief Executive Officer Grant or award +290,078 290,078
2015-01-16 Mazzo David J Chief Executive Officer Shares withheld for taxes −130,535 $3.48 $454K 159,543
2015-01-16 Mazzo David J Chief Executive Officer Returned to the company · Stock Option (right to purchase) −220,000 400,000
2015-01-16 Mazzo David J Chief Executive Officer Returned to the company · Stock Option (right to purchase) −200,000 0
2015-01-16 VATERS ROBERT S President & CFO Grant or award +137,028 137,028
2015-01-16 VATERS ROBERT S President & CFO Shares withheld for taxes −61,663 $3.48 $215K 75,365
2015-01-16 VATERS ROBERT S President & CFO Returned to the company · Stock Option (right to purchase) −80,000 400,000
2015-01-16 VATERS ROBERT S President & CFO Returned to the company · Stock Option (right to purchase) −120,000 0
2015-01-16 Smith Robin L Exec. Chairman of the Board Grant or award +39,276 329,410

Page 19 of 24 · 477 trades